"China Resources Double-Crane Pharmaceutical Co., Ltd."Announcement on Completion of the Phase III Clinical Trial of Pregabalin Sustained-Release Tablets by Wholly-owned Subsidiary China Resources Double-Crane Limin Pharmaceutical (Jinan) Co., Ltd.

Announcement on Completion of the Phase III Clinical Trial of Pregabalin Sustained-Release Tablets by Wholly-owned Subsidiary China Resources Double-Crane Limin Pharmaceutical (Jinan) Co., Ltd.

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment